Verastem, Inc.

Healthcare

NASDAQ:VSTM · NASDAQ Global Market

Market Cap $289.73M Beta 0.27 P/E (TTM) -2.1

$4.12 -0.00%

-$0.00 today

52W Low $3.55High $11.25

Vol 4.77M · Avg 2.58M

EPS (TTM) -$1.97Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-10.82%

Period High

$10.77

Period Low

$3.62

Latest

$4.12

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

$1.44B

MoonLake Immunotherapeutics

NASDAQ:MLTX

$1.42B

Absci Corporation

NASDAQ:ABSI

$1.12B

Ventyx Biosciences, Inc.

VTYX

$1.00B

Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

$991.43M

Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

$801.41M

4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

$501.85M

Prothena Corporation plc

NASDAQ:PRTA

$463.33M

REGENXBIO Inc.

NASDAQ:RGNX

$418.23M

Gossamer Bio, Inc.

GOSS

$39.47M

What is the latest VSTM filing?

The latest filing shown is 8-K dated Jun 17, 2026.

How many recent filings does VSTM have?

Intrinsic Alpha currently shows 20 recent filings for VSTM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.